Quipt Home Medical to start trading on the Nasdaq
CINCINNATI, May 26, 2021 (GLOBE NEWSWIRE) – Quipt Home Medical Corp. (“Quipt“or the”Company(TSXV: QIPT; OTCQX: PTQQD), a US home medical equipment industry leader specializing in end-to-end respiratory care, is pleased to announce that its common stock has been approved for listing on the Nasdaq Capital Marché (“Nasdaq”) Under the ticker symbol“ QIPT ”. Trading on the Nasdaq is scheduled to begin when the market opens on May 27, 2021.
“This Nasdaq listing is an incredible achievement for our company and its shareholders as we continue our mission to provide superior care to respiratory patients at home across the United States. This list reflects the substantial organizational growth of our company and our evolution as a publicly traded company over the past several years, ”commented Greg Crawford, CEO and President of Quipt. “Thanks to a multitude of strategic initiatives, we continue to build our openness of opportunities for strong organic growth and solid M&A activity in the 2nd half of the year and we are delighted to raise the public profile of our company. We believe that listing on Nasdaq will help us expand our shareholder base geographically and help provide more liquidity over time. “
The Company’s common shares will continue to be listed on the TSX Venture Exchange under the symbol “QIPT”.
ABOUT QUIPT HOME MEDICAL CORP.
The company provides home monitoring and disease management services, including end-to-end respiratory solutions for patients in the United States healthcare market. It seeks to continue to expand its offering to include the management of several chronic disease conditions with a focus on patients with heart or lung disease, sleep disorders, reduced mobility and other chronic health conditions. The Company’s primary business objective is to create shareholder value by offering a broader range of services to patients requiring home monitoring and chronic disease management. The company’s organic growth strategy is to increase annual revenue per patient by offering multiple services to the same patient, consolidating patient services and making life easier for the patient.
Certain statements contained in this press release constitute “forward-looking information” as that term is defined in applicable securities laws in Canada and the United States. The words “may”, “would”, “could”, “should”, “potential”, “will”, “seek”, “intend”, “plan”, “anticipate”, “believe”, ” estimate ”,“ expect ”and similar expressions in relation to the Company, in particular: the Company having a strong organic growth and a strong activity of mergers and acquisitions in the 2nd half; and Nasdaq listing geographically expanding the company’s shareholder base and helping to provide more liquidity over time; are intended to identify forward-looking information. All statements other than statements of historical fact may be forward-looking information. These statements reflect the current opinions and intentions of the company with respect to future events, as well as information currently available to the company, and are subject to certain risks, uncertainties and assumptions. Many factors could cause actual results, performance or achievements that could be expressed or implied by such forward-looking information to differ from those described in this document if one or more of these risks or uncertainties materialize. Examples of such risk factors include, but are not limited to: credit; market (including stocks, commodities, currencies and interest rates); liquidity; operational (including technology and infrastructure); Reputation; Insurance; strategic; regulatory; legal; environmental; capital adequacy; general commercial and economic conditions in the regions in which the Company operates; the company’s ability to execute key priorities, including successful acquisitions, business retention and strategic plans and to attract, develop and retain key executives; difficulty in integrating newly acquired businesses; The ability to implement business strategies and seize business opportunities; low profit market segments; Disruption or attacks (including cyberattacks) on information technology, the Internet, network access or other voice or data communication systems or services; the evolution of various types of fraud or other criminal behavior to which the Company is exposed; non-compliance by third parties with their obligations to the Company or its affiliates; the impact of new laws and regulations in force or their application; Lower reimbursement rates; dependence on a few payers; possible discoveries of new drugs; a new business model; Dependence on major suppliers; the granting of permits and licenses in a highly regulated business; the difficult global litigation environment, including in the United States; increased competition; changes in exchange rates; increased funding costs and market volatility due to market illiquidity and competition for funding; the availability of funds and resources to continue operations; critical accounting estimates and changes in accounting standards, policies and methods used by the company; the occurrence of natural and unnatural catastrophic events and claims resulting from such events; and the risks associated with COVID-19, including various recommendations, orders and measures by government authorities in an attempt to limit the pandemic, including travel restrictions, border closures, non-essential business closures, quarantines, self-isolation, shelter in place and social distancing, disruption of markets, economic activity, financing, supply chains and sales channels, and a deterioration in general economic conditions, including a possible national recession or global; as well as the risk factors discussed or mentioned in the company’s disclosure documents filed with the United States Securities and Exchange Commission and available at www.sec.gov and with the securities regulatory authorities of certain provinces Canada and available at www.sedar.com. If any factor unexpectedly affects the Company, or if the assumptions underlying the forward-looking information prove to be incorrect, actual results or events may differ materially from expected results or events. This forward-looking information is expressly qualified in its entirety by this warning. In addition, the Company assumes no responsibility for the accuracy or completeness of this forward-looking information. The forward-looking information included in this press release is made as of the date of this press release and the Company does not undertake to publicly update or revise any forward-looking information, other than required by applicable law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For more information, please visit our website at www.quipthomemedical.com, or contact:
Vice President of Corporate Development
Quipt Home Medical Corp.
Chief executive officer
Quipt Home Medical Corp.